Griner P F, Elbadawi A, Packman C H
Ann Intern Med. 1976 Nov;85(5):578-82. doi: 10.7326/0003-4819-85-5-578.
Two adult male patients with acute leukemia developed a fatal Budd-Chiari-like illness while receiving 6-thioguanine. Both had previously received cytosine arabinoside. Antemortem and postmortem specimens of liver showed changes characteristic of toxic veno-occlusive disease. Similar findings have been described after ingestion of certain plant alkaloids and after treatment with arsphenamine, urethane, and ionizing radiation to the liver. We are unaware of any published reports of veno-occlusive disease of the liver after treatment with either 6-thioguanine or cytosine arabinoside. Although 6-thioguanine was most likely responsible for this syndrome, it is not possible to eliminate cytosine arabinoside as the causative agent. Since both drugs are occasionally used for benign conditions, physicians should be aware of this possible complication.
两名成年男性急性白血病患者在接受6-硫鸟嘌呤治疗时发生了致命的布-加样疾病。两人此前均接受过阿糖胞苷治疗。肝脏的生前和死后标本显示出中毒性静脉闭塞性疾病的特征性变化。摄入某些植物生物碱后以及用胂凡纳明、氨基甲酸乙酯和肝脏电离辐射治疗后也有类似发现。我们未发现任何关于用6-硫鸟嘌呤或阿糖胞苷治疗后发生肝脏静脉闭塞性疾病的已发表报告。虽然6-硫鸟嘌呤最有可能是该综合征的病因,但无法排除阿糖胞苷作为致病因素。由于这两种药物偶尔也用于良性疾病,医生应意识到这种可能的并发症。